Literature DB >> 31988107

Be Careful with Adverse Events Caused by Cefoperazone-Sulbactam.

Xianshi Zhou1,2, Fanwei Wu3.   

Abstract

Entities:  

Year:  2020        PMID： 31988107      PMCID： PMC6985757          DOI： 10.1128/AAC.01942-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  4 in total

Review 1.  Intention-to-treat principle.

Authors:  V M Montori; G H Guyatt
Journal:  CMAJ       Date:  2001-11-13       Impact factor: 8.262

Review 2.  Inclusion of patients in clinical trial analysis: the intention-to-treat principle.

Authors:  Stephane R Heritier; Val J Gebski; Anthony C Keech
Journal:  Med J Aust       Date:  2003-10-20       Impact factor: 7.738

3.  Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.

Authors:  Jien-Wei Liu; Yen-Hsu Chen; Wen-Sen Lee; Jung-Chung Lin; Ching-Tai Huang; Hsi-Hsun Lin; Yung-Ching Liu; Yin-Ching Chuang; Hung-Jen Tang; Yao-Shen Chen; Wen-Chien Ko; Min-Chi Lu; Fu-Der Wang
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

Review 4.  Obesity survival paradox in pneumonia: a meta-analysis.

Authors:  Wei Nie; Yi Zhang; Sun Ha Jee; Keum Ji Jung; Bing Li; Qingyu Xiu
Journal:  BMC Med       Date:  2014-04-10       Impact factor: 8.775
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.